sign up
sign up electronically
(as of March 31, 2013)
|
Shares of Common Stock Issued and Outstanding Series B Cumulative Convertible Preferred Stock (1) Authorized Preferred Shares (none outstanding) Stock Options Unvested, restricted stock units Warrants Fully Diluted (2) |
285,163,224 157,816 5,000,000 905,408 1,037,147 22,332,623 309,945,402 |
(1) Our 157,816 outstanding shares of Series B preferred stock are convertible at the option of the holders to a total of approximately 0.5 million shares of our common stock. The stock is redeemable at the option of the company, in whole or in part, at $50.00 per share.
(2) Fully diluted shares outstanding is an estimate of the number of common shares that would be outstanding if all shares of preferred stock, stock options, restricted stock units, and warrants outstanding or unvested as of March 31, 2013, were converted, exercised or vested, resulting the issuance of shares of our common stock. A majority of the unvested restricted units at March 31, 2013, vest at dates ranging from 2013 to 2015.
| Warrants Outstanding | Warrants | Exercise Price | Expiration Date | ||
|
Series 1 Series 1 Series 3 |
460,976 5,200,519 16,671,128 22,332,623 |
$2.52 $2.41 $2.46 |
June 2014 June 2014 August 2014 |
The warrants are not publicly traded. Warrants outstanding at March 31, 2013, expire in June or August 2014 and stock options outstanding at March 31, 2013, have expiration dates ranging from 2013 to 2015. No assurance can be given as to how many of the outstanding warrants and stock options will be exercised prior to their expiration dates, or the timing of such exercises.
The expected proceeds from exercises of any outstanding Series 1 and Series 3 warrants are obligated as a portion of settlement payments in the Coeur d'Alene Basin Consent Decree.